Neoadjuvant Durvalumab in non-surgical early stage/locally advanced non-small cell lung cancer (NSCLC) followed by radical RT/CRT (IDEAR)-Study concept of a Phase II Investigator initiated clinical trial
Durvalumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Neoadjuvant Durvalumab in non-surgical early stage/locally advanced non-small cell lung cancer (NSCLC) followed by radical RT/CRT (IDEAR)-Study concept of a Phase II Investigator initiated clinical trial ### Output: Durvalumab